TD Waterhouse Canada’s Inovio Pharmaceuticals INO Stock Holding History

TD Waterhouse Canada’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71	Hold	41	–	–	﹤0.01%	2237
2025 Q4	$71	Hold	41	–	–	﹤0.01%	1985
2025 Q3	$97	Sell	41 -5	-11%	-$10	﹤0.01%	1997
2025 Q2	$94	Hold	46	–	–	﹤0.01%	1915
2025 Q1	$69	Hold	46	–	–	﹤0.01%	1878
2024 Q4	$84	Hold	46	–	–	﹤0.01%	1893
2024 Q3	$259	Hold	46	–	–	﹤0.01%	1787
2024 Q2	$396	Buy	+46	New	+$484	﹤0.01%	1787
2024 Q1	–	Sell	-48	Closed	-$329	–	1850
2023 Q4	$329	Sell	48 -41	-46%	-$202	﹤0.01%	1616
2023 Q3	$412	Hold	89	–	–	﹤0.01%	1609
2023 Q2	$482	Hold	89	–	–	﹤0.01%	1653
2023 Q1	$840	Hold	89	–	–	﹤0.01%	1612
2022 Q4	$1.63K	Sell	89 -36	-29%	-$816	﹤0.01%	1508
2022 Q3	$2.88K	Buy	125 +42	+51%	+$1.07K	﹤0.01%	1450
2022 Q2	$1.88K	Hold	83	–	–	﹤0.01%	1545
2022 Q1	$3.79K	Sell	83 -538	-87%	-$24.2K	﹤0.01%	1500
2021 Q4	$37.4K	Buy	+621	New	+$49.8K	﹤0.01%	1064

Other funds holding INO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Waterhouse Canada's INO Position: Q1 2026 in Review

TD Waterhouse Canada held its Inovio Pharmaceuticals (INO) position steady in Q1 2026 at 41 shares worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

TD Waterhouse Canada first reported a position in INO in Q4 2021 and has held it in 17 quarters since. The position peaked at $37.4K in Q4 2021. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

TD Waterhouse Canada held 41 shares of Inovio Pharmaceuticals worth $71 as of Q1 2026.
TD Waterhouse Canada left its Inovio Pharmaceuticals share count unchanged in Q1 2026.
Inovio Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2237 holding.
TD Waterhouse Canada first reported a position in Inovio Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
TD Waterhouse Canada's Inovio Pharmaceuticals position peaked at $37.4K in Q4 2021.
100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.